CREB1 and Huntington disease: As summarized in Fig. 4, we show that mGluR5 antagonism represents an effective approach to potentially halt HD progression by reversing mTOR-mediated inhibition of autophagy to reduce mHTT aggregates, and facilitate CREB-mediated expression of BDNF.